Mutations in LMOD3 cause severe congenital nemaline myopathy by disrupting sarcomeric thin filament organization.
No takes yet. Share an insight, caveat, or question.
LMOD3 testing may aid severe NM diagnosis; leaves open targeted therapies pending validation.
Yuen et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: